What is Integra Lifesciences Holdings’ earnings per share excluding NRI?
Integra Lifesciences Holdings’ earnings per share excluding one-off items for the three months ended June 2024 Was 0,59 €Earnings per share excluding one-off effects for the Last twelve months (TTM) ended in June 2024 Was 2,62 €.
During the last 12 monthsIntegra Lifesciences Holdings Average Earnings Per Share (NRI) Growth rate Was 11.70% per year. During the last 3 yearsthe average earnings per share (NRI) Growth rate Was -18.80% per year. During the last 5 yearsthe average earnings per share (NRI) Growth rate Was 7.50% per year. During the last 10 yearsthe average earnings per share (NRI) Growth rate Was 19.00% per year. Please click Example of calculating the growth rate (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT) sales growth rate. You can apply the same method to find the earnings per share excluding NRI growth rate by using earnings per share excluding non-recurring items (NRI).
The historical rank and industry rank for Integra Lifesciences Holdings’ earnings per share excluding NRI or its related term are shown as follows:
During the last 13 yearsIntegra Lifesciences Holdings highest The average growth rate of earnings per share (NRI) over 3 years was 93.10% per year. The lowest Was -48.20% per year. And the medium Was 7.90% per year.
Integra Lifesciences Holdings EPS (diluted) for the three months until June 2024 Was -0,15 €. It is EPS (diluted) for the Last twelve months (TTM) ended in June 2024 Was 0,27 €.
Integra Lifesciences Holdings EPS (base) for the three months until June 2024 Was -0,15 €. It is EPS (base) for the Last twelve months (TTM) ended in June 2024 Was 0,27 €.
Integra Lifesciences Holdings EPS ex NRI Historical Data
The historical data trend for Integra Lifesciences Holdings Earnings per Share (EPS) excluding NRI is shown below:
* For the Operating Data section: All numbers are indicated by the unit following each term and all currency-related amounts are in USD.
* For other sections: All figures are in millions, except per share, ratio and percent amounts. All currency related amounts are stated in the Company’s respective exchange currency.
Integra Lifesciences Holdings EPS without NRI chart
Competitive comparison of Integra Lifesciences Holdings EPS excluding NRI
For the Medical devices Sub-Industry: Integra Lifesciences Holdings’s P/E excluding NRI as well as competitors’ market caps and P/E excluding NRI data can be viewed below:
* Competing companies are selected from companies in the same industry, headquartered in the same country and with similar market capitalization. The X-axis shows the market capitalization and the Y-axis shows the maturity value. The larger the dot, the higher the market capitalization. Note that “N/A” values are not shown in the chart.
P/E ratio of Integra Lifesciences Holdings excluding NRI distribution in the medical device and instrument industry
For the Medical devices and instruments Industry and Healthcare Sector, Integra Lifesciences Holdings P/E ratio without NRI distribution charts can be found below:
* The red bar shows where Integra Lifesciences Holdings’ P/E ratio is without NRI.
Integra Lifesciences Holdings EPS without NRI calculation
Earnings per share (EPS) is the most important variable used by Wall Street to determine a company’s earnings power. However, investors must be aware that EPS can be easily manipulated by adjusting the depreciation and amortization rate or one-time items. For this reason, GuruFocus lists EPS without NRI, which better reflects the company’s underlying performance.
Earnings per share excluding non-recurring items is the sum of earnings excluding non-recurring items for each share of stock outstanding in the company.
Earnings per share excluding NRI for the trailing twelve months (TTM) to June 2024 adds up the quarterly data reported by the company in the last 12 months, which was €2.62.
* For the Operating Data section: All numbers are indicated by the unit following each term and all currency-related amounts are in USD.
* For other sections: All figures are in millions, except per share, ratio and percent amounts. All currency related amounts are stated in the Company’s respective exchange currency.
EPS excluding NRI removes one-off and unusual items from EPS to provide investors with a more accurate measure of the company’s actual earnings. Earnings are adjusted for items that are irregular, unusual and/or non-recurring. This is calculated using Net profit (continuing operations) plus/minus any taxable special items and impairment/amortization of goodwill. This can be used to fairly measure the profitability of a company.
Compared to earnings per share, a company’s cash flow is a better indicator of its profitability.
If a company’s earnings per share are below its cash flow per share over the long term, investors need to be cautious and find out the reasons behind this.
Integra Lifesciences Holdings EPS excluding NRI-related terms
Thanks for checking out the detailed overview of Integra Lifesciences Holdings EPS excluding NRI by GuruFocus.com. Please click on the following links to view the pages with related terms.
EPS (diluted)
EPS (base)
Example of calculating the growth rate (GuruFocus)
Integra Lifesciences Holdings Business Description
Traded on other exchanges
address
1100 Campus Road, Princeton, NJ, USA, 08540
Integra Lifesciences Holdings Corp is a New Jersey-based medical device company focused on developing products for regenerative therapy, extremity orthopedics and neurosurgical applications. The company is organized into two main segments: Codman Specialty Surgical and Tissue Technologies. Codman Specialty Surgical generates the majority of its revenue from its segment activities. Integra serves Europe, Asia Pacific and the rest of the world, while it generates the majority of its revenue from domestic sales.
